BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 474138)

  • 21. Studies on stability testing in pharmaceutical formulation.
    Lundgren P
    Acta Pharm Suec; 1971 Jun; 8(3):169-92. PubMed ID: 5314840
    [No Abstract]   [Full Text] [Related]  

  • 22. Stability and compatibility studies of cefaloridine, cefuroxime and ceftazidime with PVC infusion bags.
    Faouzi MA; Dine T; Luyckx M; Gressier B; Brunet C; Goudaliez F; Mallevais ML; Cazin M; Cazin JC
    Pharmazie; 1994 Jun; 49(6):425-7. PubMed ID: 8047543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous intravenous administration of drugs.
    Paris P; Hans P; Lamy M
    Acta Anaesthesiol Belg; 1983 Jun; 34(2):109-15. PubMed ID: 6613510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate 'dose-banding'.
    Kaestner S; Sewell G
    J Oncol Pharm Pract; 2007 Jun; 13(2):119-26. PubMed ID: 17873112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of plastic containers for intravenous solutions.
    Kerkhof K
    Am J Hosp Pharm; 1979 Aug; 36(8):1028, 1035-6. PubMed ID: 484558
    [No Abstract]   [Full Text] [Related]  

  • 26. [Regulations for infusions. Contribution to the improvement of safety in the use of infusion and injection solutions].
    Fürtig W; Frick U
    Dtsch Gesundheitsw; 1969 Jun; 24(25):1182-5. PubMed ID: 5376169
    [No Abstract]   [Full Text] [Related]  

  • 27. Thiamine destruction by sodium bisulfite in infusion solutions.
    Scheiner JM; Araujo MM; DeRitter E
    Am J Hosp Pharm; 1981 Dec; 38(12):1911-3. PubMed ID: 7325171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of stability and expiration time of infusion solutions].
    Opletal Z; Seidl R; Blazek J
    Cesk Farm; 1966 Jan; 15(1):34-8. PubMed ID: 5907952
    [No Abstract]   [Full Text] [Related]  

  • 29. [Activity loss of antibiotics in infusion solutions].
    Lode H; Küpper G
    Verh Dtsch Ges Inn Med; 1973; 79():1438-40. PubMed ID: 4790207
    [No Abstract]   [Full Text] [Related]  

  • 30. [Stability of amino acid infusion solutions. 3. Influence of certain factors on the stability of amino acid infusion solutions].
    Seydel H; Voigt R
    Pharmazie; 1972 Oct; 27(10):660-9. PubMed ID: 4636479
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of compounding and storage conditions on stability of pergolide mesylate.
    Davis JL; Kirk LM; Davidson GS; Papich MG
    J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Special problems in the development of modern infusion solutions].
    Frank P
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1970 Mar; 40(3):77-88. PubMed ID: 5467832
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of the Reorganization of Drug Legislation "Act" on the production and admission of infusion solutions].
    Mohrbutter K; Schnieders B; Schuster J; Wolff U
    Klin Anasthesiol Intensivther; 1977; (14):74-88. PubMed ID: 926693
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ensuring the sterility of infusion solutions].
    Meyer KH; Bickel H
    Klin Anasthesiol Intensivther; 1977; (14):18-20. PubMed ID: 926685
    [No Abstract]   [Full Text] [Related]  

  • 35. Continuous versus intermittent intravenous antibiotics.
    Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663
    [No Abstract]   [Full Text] [Related]  

  • 36. [Possibilities and significance of the production of infusion solutions in hospital pharmacies].
    Frank P
    Infusionstherapie (1973); 1974 Apr; 1(4):319-23. PubMed ID: 4219374
    [No Abstract]   [Full Text] [Related]  

  • 37. [Shelf life of injection solutions and eyedrops prepared under field conditions].
    Riabykh LD; Khveshchuk PF
    Voen Med Zh; 1978 Jul; (7):81-2. PubMed ID: 676174
    [No Abstract]   [Full Text] [Related]  

  • 38. Stability of parenteral midazolam in an oral formulation.
    Walker SE; Grad HA; Haas DA; Mayer A
    Anesth Prog; 1997; 44(1):17-22. PubMed ID: 9481976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation development of frozen parenteral dosage forms.
    Chilamkurti RN
    J Parenter Sci Technol; 1992; 46(4):124-9. PubMed ID: 1453281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Laboratory and clinical experience with infusion solutions having an extended expiration time].
    Opletal Z; Kolár V; Seidl R; Blazek J
    Cesk Farm; 1967 Oct; 16(8):400-1. PubMed ID: 6076698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.